MediciNova,Inc.

Corporate Details

ISIN(s):

N/A

LEI:

Country:

Japan

Address:

米国カリフォルニア州ラ・ホイヤ、スウィート３００、エグゼクティブ・スクエア４２７５

Website:

https://medicinova.com/

Sector:

Health Care

Industry:

Pharmaceuticals

Description

MediciNova, Inc. is a Japanese biopharmaceutical company dedicated to developing innovative therapeutics targeting neurology, respiratory, and liver diseases that currently lack effective treatments. The company's lead product, MN-221, is aimed at addressing acute exacerbations in asthma and chronic obstructive pulmonary disease (COPD). Additionally, MediciNova is advancing MN-001, a therapeutic candidate focused on fibrotic diseases, including liver fibrosis related to non-alcoholic steatohepatitis (NASH) and pulmonary fibrosis associated with idiopathic pulmonary fibrosis (IPF). With a commitment to addressing unmet medical needs, MediciNova strives to improve patient outcomes through its cutting-edge research and development efforts.